Results 21 to 30 of about 1,365,518 (224)

Bluetongue in Belgium, 2006

Emerging Infectious Diseases, 2007
Bluetongue has emerged recently in Belgium. A bluetongue virus strain was isolated and characterized as serotype 8. Two new real-time reverse transcription–quantitative PCRs (RT-qPCRs) that amplified 2 different segments of bluetongue virus detected this
Jean-François Toussaint, Corinne Sailleau, Jan Mast, Philippe Houdart, Guy Czaplicki, Lien Demeestere, Frank Vandenbussche, Wesley van Dessel, Nesya Goris, Emmanuel Bréard, Lotfi Bounaadja, Etienne Thiry, Stephan Zientara, Kris De Clercq   +13 more
doaj   +1 more source

Bluetongue Virus in Lebanon

Transboundary and Emerging Diseases, 2013
Since 2000, several incursions of bluetongue virus (BTV) occurred in the Mediterranean Basin involving European and surrounding Countries. The Middle East represents one of the most important gateways for the access of BTV in Europe. Limited data on the BTV situation in this area are available.
El Hage, J., Lorusso, A., Carmine, I., Di Gennaro, A., Portanti, O., Olivieri, S., Casaccia, C., Pisciella, M., Teodori, L., Sghaier, S., Savini, G.   +10 more
openaire   +2 more sources

Seroprevalence of bluetongue serotype 8 in cattle in the Netherlands in spring 2007, and its consequences [PDF]

, 2008
A cross-sectional study was carried out in spring 2007, at the end of the first bluetongue outbreak season, to determine the geographical spread of bluetongue virus serotype 8 (BTV-8) infection in cattle in the Netherlands and the consequences for some ...
Vellema, P., Schaik, G., van, Langen, H., Berends, I.M.G.A., Elbers, A.R.W.   +4 more
core   +1 more source

Quantitative analysis of transmission parameters for bluetongue virus serotype 8 in Western Europe in 2006 [PDF]

, 2011
The recent bluetongue virus serotype 8 (BTV-8) epidemic in Western Europe struck hard. Controlling the infection was difficult and a good and safe vaccine was not available until the spring of 2008.
de Koeijer Aline A, Estelle Meroc, Koeijer, A.A., de, Meroc, E., Boender Gert, Staubach Christoph, Elbers, A.R., Gonnie Nodelijk, Armin RW Elbers, de Koeijer, A.A., Aline A de Koeijer, Nodelijk Gonnie, Boender, G.J., Gert Boender, Staubach, C., Christoph Staubach, Elbers Armin RW, Nodelijk, G., Meroc Estelle, Staubach, Christoph, Elbers, A.R.W.   +20 more
core   +1 more source

Characterization of protection afforded by a bivalent virus-like particle vaccine against bluetongue virus serotypes 1 and 4 in sheep. [PDF]

PLoS ONE, 2011
BACKGROUND: Bluetongue virus (BTV) is an economically important, arthropod borne, emerging pathogen in Europe, causing disease mainly in sheep and cattle.
Ana Cristina Pérez de Diego, Thimmasandra N Athmaram, Meredith Stewart, Belén Rodríguez-Sánchez, José Manuel Sánchez-Vizcaíno, Robert Noad, Polly Roy   +6 more
doaj   +1 more source

Bluetongue virus non-structural protein 1 is a positive regulator of viral protein synthesis. [PDF]

, 2012
BACKGROUND: Bluetongue virus (BTV) is a double-stranded RNA (dsRNA) virus of the Reoviridae family, which encodes its genes in ten linear dsRNA segments.
Roy Polly, Boyce, Mark, Roy, Polly, Celma, Cristina CP, Cristina C P Celma, Boyce Mark, Mark Boyce, Polly Roy, Celma Cristina C P   +8 more
core   +1 more source

Full Genome Characterisation of Bluetonge Virus Seroptype 6 from the Netherlands 2008 and Comparison to Other Field and Vaccine Strains [PDF]

, 2010
In mid September 2008, clinical signs of bluetongue (particularly coronitis) were observed in cows on three different farms in eastern Netherlands (Luttenberg, Heeten, and Barchem), two of which had been vaccinated with an inactivated BTV-8 vaccine ...
Hoffmann, B., Wright Isabel M., Eschbaumer, M., Anna Sanders, Kyriaki Nomikou, Carrie Batten, van Rijn, Piet A., Maan, S., René G P van Gennip, Gennip, H.G.P., van, Chris A L Oura, van Gennip René G. P., Batten Carrie, Maan, Sushila, van Rijn, P.A., Oura Chris A. L., Sanders, Anna, Mertens, P.P.C., Eschbaumer, Michael, Mertens, Peter P.C., van Rijn Piet A., Oura, Chris A. L., Potgieter, C., Sushila Maan, Peter P C Mertens, Eschbaumer Michael, Hoffmann, Bernd, Maan, N.S., Wright, I.M., Potgieter, Abraham C., Narender S Maan, Nomikou, K., Nomikou Kyriaki, van Gennip, René G. P., Abraham C Potgieter, Oura, C.A.L., Bernd Hoffmann, Wright, Isabel M., Sanders Anna, Potgieter Abraham C., Maan Sushila, Piet A van Rijn, Maan Narender S., Hoffmann Bernd, Batten, Carrie, Isabel M Wright, Rijn, P.A., van, Batten, C., Maan, Narender S., Mertens Peter P.C., Sanders, A.A., Michael Eschbaumer, Nomikou, Kyriaki, Potgieter, A.C., van Gennip, R.G.P., Sanders, A.   +55 more
core   +1 more source

RNA interference targets arbovirus replication in Culicoides cells [PDF]

, 2013
Arboviruses are transmitted to vertebrate hosts by biting arthropod vectors such as mosquitoes, ticks and midges. These viruses replicate in both arthropods and vertebrates and are thus exposed to different antiviral responses in these organisms.
Varela, Mariana, Esther Schnettler, Ratinier, Maxime, Shaw, Andrew, Palmarini, Massimo, Kohl, Alain, Mariana Varela, Mick Watson, Elliott, Richard M., Alain Kohl, Maxime Ratinier, McFarlane, Melanie, Shaw, Andrew E., Elliott, Richard, Richard M, Massimo Palmarini, Schnettler, Esther, E. Shaw, Watson, Mick, A Alain Kohla, Melanie Mcfarlane   +20 more
core   +1 more source

Monitoring of Putative Vectors of Bluetongue Virus Serotype 8, Germany

Emerging Infectious Diseases, 2009
To identify the vectors of bluetongue virus (BTV) in Germany, we monitored Culicoides spp. biting midges during April 2007–May 2008. Molecular characterization of batches of midges that tested positive for BTV suggests C.
Bernd Hoffmann, Burkhard Bauer, Christian Bauer, Hans-Joachim Bätza, Martin Beer, Peter-Henning Clausen, Martin Geier, Jörn M. Gethmann, Ellen Kiel, Gabriele Liebisch, Arndt Liebisch, Heinz Mehlhorn, Günter A. Schaub, Doreen Werner, Franz J. Conraths   +14 more
doaj   +1 more source

Did vaccination slow the spread of bluetongue in France? [PDF]

PLoS ONE, 2014
Vaccination is one of the most efficient ways to control the spread of infectious diseases. Simulations are now widely used to assess how vaccination can limit disease spread as well as mitigate morbidity or mortality in susceptible populations. However,
Maryline Pioz, Hélène Guis, David Pleydell, Emilie Gay, Didier Calavas, Benoît Durand, Christian Ducrot, Renaud Lancelot   +7 more
doaj   +1 more source